Literature DB >> 10592423

Evaluation of treatment of hyperemesis gravidarum using parenteral fluid with or without diazepam. A randomized study.

A Ditto1, G Morgante, A la Marca, V De Leo.   

Abstract

OBJECTIVE: Hyperemesis gravidarum is a relatively unknown disease, and is generally self-limiting. In some women the symptoms are so severe as to threaten the health of the mother and fetus. Therapies proposed for hyperemesis gravidarum are therefore rather empirical. Medical treatment includes parenteral fluid replacement and nutrition, electrolytes, antiemetics, vitamins, sedation and psychological counseling. Diazepam and benzodiazepines have been widely studied in pregnancy but the results are contradictory. The aim of the present study was to investigate the efficacy of parenteral fluids with vitamins, with or without diazepam sedation.
METHODS: Fifty women with hyperemesis gravidarum were enrolled in the study. They were treated with infusions of normal saline, glucose, vitamins and randomly with diazepam.
RESULTS: The results show that the mean stay in the hospital was shorter in the diazepam group: 4.5 +/- 1.9 vs. 6 +/- 1.6 days (p < 0.05) and readmission to the hospital was 4% in the diazepam group versus 27% in other group (p < 0.05). There was a significant reduction in nausea in the diazepam group (p < 0.05). A significant reduction in vomiting was observed in both groups. No side effects or congenital neonatal malformations were found in the diazepam group.
CONCLUSIONS: Intravenous administration of fluids and vitamins is the standard treatment for women hospitalized for hyperemesis gravidarum. The addition of diazepam to the treatment is effective in reducing nausea and does not have teratogenic effects. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592423     DOI: 10.1159/000010189

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

Review 1.  Hyperemesis gravidarum: current concepts and management.

Authors:  N K Kuşcu; F Koyuncu
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

2.  A case of treatment refractory hyperemesis gravidarum in a patient with comorbid anxiety, treated successfully with adjunctive gabapentin: a review and the potential role of neurogastroentereology in understanding its pathogenesis and treatment.

Authors:  David R Spiegel; Kathryn Webb
Journal:  Innov Clin Neurosci       Date:  2012-11

Review 3.  Managing hyperemesis gravidarum: a multimodal challenge.

Authors:  J K Jueckstock; R Kaestner; I Mylonas
Journal:  BMC Med       Date:  2010-07-15       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.